Filtered By:
Source: Value in Health
Countries: Kazakhstan Health

This page shows you your search results in order of date.

Order by Relevance | Date

Total 1 results found since Jan 2013.

Cost-Effectiveness of Apixaban For Stroke Prevention In Atrial Fibrillation: An Kazakhstan Perspective
The objective of this study was to evaluate the cost-effectiveness of apixaban against other NOACs and warfarin from the considering costs and savings for public payers perspective in Kazakhstan
Source: Value in Health - October 1, 2017 Category: International Medicine & Public Health Authors: A Kostyuk, A Almadiyeva, T Nurgozhin Source Type: research